The Middle East & Africa digital thoracic drainage devices market is expected to grow from US$ 4.65 million in 2022 to US$ 6.23 million by 2030. It is estimated to grow at a CAGR of 3.7% from 2022 to 2030.
This development holds immense potential for earlier and more precise diagnoses, particularly in conditions like lung cancer, where early detection significantly impacts survival rates. AI can rapidly analyze large volumes of imaging data, allowing radiologists and clinicians to focus on more complex cases, interpret results with greater confidence, and expedite treatment decisions. Additionally, AI-driven predictive models can help access disease progression and treatment responses over time, aiding in personalized patient care.
The integration of AI into thoracic diagnostics represents a paradigm shift, promising to enhance the efficiency and effectiveness of respiratory healthcare, ultimately leading to enhanced patient results and a more sustainable healthcare system.
Based on product type, the Middle East & Africa digital thoracic drainage devices market is segmented into single chamber and multiple chambers. The single chamber segment held a larger share of the Middle East & Africa digital thoracic drainage devices market in 2022.
Based on application, the Middle East & Africa digital thoracic drainage devices market is segmented into cardiac surgery, thoracic and pulmonary surgery, oncology and trauma, infectious diseases, and others. The thoracic and pulmonary surgery segment held the largest share of the Middle East & Africa digital thoracic drainage devices market in 2022.
Based on end user, the Middle East & Africa digital thoracic drainage devices market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the Middle East & Africa digital thoracic drainage devices market in 2022.
Based on country, the Middle East & Africa digital thoracic drainage devices market is segmented int o the UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa digital thoracic drainage devices market in 2022.
Cardinal Health Inc, Getinge AB, Medela AG, Redax SpA, and Teleflex Inc are some of the leading companies operating in the Middle East & Africa digital thoracic drainage devices market.
AI-Powered Thoracic Diagnostics Fuels Middle East & Africa Digital Thoracic Drainage Devices Market
The future of digital thoracic diagnostics is poised for a transformative shift, primarily fueled by the integration of Artificial Intelligence (AI) into the field. AI-enhanced diagnostics represent a pioneering trend that promises to revolutionize how thoracic conditions are detected and managed. Advanced machine learning algorithms, trained on a vast dataset of thoracic images, can quickly and accurately identify abnormalities, ranging from lung nodules to subtle lung tissue changes.This development holds immense potential for earlier and more precise diagnoses, particularly in conditions like lung cancer, where early detection significantly impacts survival rates. AI can rapidly analyze large volumes of imaging data, allowing radiologists and clinicians to focus on more complex cases, interpret results with greater confidence, and expedite treatment decisions. Additionally, AI-driven predictive models can help access disease progression and treatment responses over time, aiding in personalized patient care.
The integration of AI into thoracic diagnostics represents a paradigm shift, promising to enhance the efficiency and effectiveness of respiratory healthcare, ultimately leading to enhanced patient results and a more sustainable healthcare system.
Middle East & Africa Digital Thoracic Drainage Devices Market Overview
The Middle East & Africa digital thoracic drainage devices market is segmented into the UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. increase in the geriatric population, an upsurge in cardiothoracic abnormalities, a higher rate of diagnosis and surgical treatment of cardiothoracic abnormalities, and the development of healthcare infrastructure. The increasing prevalence of pneumothorax is one of the prime reasons driving the growth of the Middle East & Africa digital thoracic drainage devices market in Saudi Arabia. Chest pain, tachypnea, dyspnea, dry cough, subcutaneous emphysema, respiratory distress indicators, tiredness, hypotension, and tachycardia are a few of the symptoms of pneumothorax. Possible reasons for ruptured or damaged chest or lung walls include lung disease, assisted breathing with a ventilator, sports or accident injuries, or fluctuations in air pressure during scuba diving or mountain climbing. On the other hand, the etiology of pneumothorax is unknown sometimes. The study"Characteristics of Neonatal Pneumothorax in Saudi Arabia" was conducted with 2,204 infants admitted to the neonatal intensive care unit (NICU) at King Fahad Medical City, Saudi Arabia, which involved the records of newborns with pneumothorax. Around 86 patients were diagnosed with pneumothorax, with an incidence of 3.9%, and 25 newborns with pneumothorax died. Thus, such a high incidence of pneumothorax fuels the Middle East & Africa digital thoracic drainage devices market in Saudi Arabia.Middle East & Africa Digital Thoracic Drainage Devices Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Digital Thoracic Drainage Devices Market Segmentation
The Middle East & Africa digital thoracic drainage devices market is segmented into product type, application, end user, and country.Based on product type, the Middle East & Africa digital thoracic drainage devices market is segmented into single chamber and multiple chambers. The single chamber segment held a larger share of the Middle East & Africa digital thoracic drainage devices market in 2022.
Based on application, the Middle East & Africa digital thoracic drainage devices market is segmented into cardiac surgery, thoracic and pulmonary surgery, oncology and trauma, infectious diseases, and others. The thoracic and pulmonary surgery segment held the largest share of the Middle East & Africa digital thoracic drainage devices market in 2022.
Based on end user, the Middle East & Africa digital thoracic drainage devices market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the Middle East & Africa digital thoracic drainage devices market in 2022.
Based on country, the Middle East & Africa digital thoracic drainage devices market is segmented int o the UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa digital thoracic drainage devices market in 2022.
Cardinal Health Inc, Getinge AB, Medela AG, Redax SpA, and Teleflex Inc are some of the leading companies operating in the Middle East & Africa digital thoracic drainage devices market.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Middle East & Africa Digital Thoracic Drainage Devices Market Landscape
5. Middle East & Africa Digital Thoracic Drainage Devices Market - Key Industry Dynamics
6. Digital Thoracic Drainage Devices Market - Middle East & Africa Market Analysis
7. Middle East & Africa Digital Thoracic Drainage Devices Market - Revenue and Forecast to 2030 - by Product Type
8. Middle East & Africa Digital Thoracic Drainage Devices Market - Revenue and Forecast to 2030 - by Application
9. Middle East & Africa Digital Thoracic Drainage Devices Market - Revenue and Forecast to 2030 - by End User
10. Middle East & Africa Digital Thoracic Drainage Devices Market - Country Analysis
11. Middle East & Africa Digital Thoracic Drainage Devices Market Industry Landscape
12. Middle East & Africa Digital Thoracic Drainage Devices Market, Key Company Profiles
13. Appendix
List of Tables
List of Figures
Executive Summary
At 3.7% CAGR, the Middle East & Africa Digital Thoracic Drainage Devices Market is speculated to be worth US$ 6.23 million by 2030.According to this research, the Middle East & Africa digital thoracic drainage devices market was valued at US$ 4.65 million in 2022 and is expected to reach US$ 6.23 million by 2030, registering a CAGR of 3.7% from 2022 to 2030. Need for digital thoracic drainage post-thoracic surgery and advantages of digital thoracic drainage devices over analog thoracic drainage devices are among the critical factors attributed to the Middle East & Africa digital thoracic drainage devices market expansion.
The count of thoracic surgeries performed is increasing due to the rising incidence of lung cancer. ~80% of the total thoracic surgeries are performed for the treatment of lung cancer and its types. The type of lung cancer includes oesophageal cancer and the cancers diagnosed in the pericardium, the chest wall, and mediastinum tumors. According to the World Cancer Research Fund International, lung cancer is the second most common cancer worldwide. The number of thoracic surgeries performed worldwide has increased notably with the prevalence of the disease and a surge in its diagnosis. The number of thoracic surgeries would continue to increase in the coming years with the rising incidence of lung cancer. Thus, the demand for digital thoracic drainage devices is increasing with the rising incidence of lung cancer. The field of thoracic surgery is growing technically and technologically into a prominent surgical specialty. Thoracic surgery has witnessed progress due to the developments made in the minimally invasive approaches. In addition, the developments have been made for peri-operative care also it has integrated surgery into treatment of chest diseases through multi-modality treatment.
Further procedures, such as elective segmentectomy, enhanced recovery programs, uniport surgery, and adjuvant target therapy has allowed treatments for early-stage lung cancer, resulting in increasing number of thoracic surgeries. Moreover, the number of thoracic surgeries is increasing with technical developments, leading to much better results than surgeries performed a decade ago. Most thoracic surgeries are performed robotically or by video-assisted thoracoscopic surgery (VATS) lobectomy, which results in fewer complications and faster recovery. Thoracic drainage devices are essential post-surgery to remove large air leakage and excessive fluid from the pleural cavity. Apart from lung cancers, thoracic surgeries are performed for treating cardiovascular diseases and other chronic diseases. These procedures also include first rib resection for thoracic outlet syndrome, myotomy for Achalasia, esophagectomy and reconstruction for end-stage benign oesophageal disease, thymectomy for Myasthenia Gravis, sympathectomy for hyperhidrosis, and so on. These diseases are common among elderlies, and people suffering from respiratory disorders and other health conditions. Thus, a rise in the geriatric population triggers the number of thoracic surgeries performed as a treatment, thereby leading to the need for digital thoracic drainage devices.
On the contrary, lack of skilled personnel hampers the Middle East & Africa digital thoracic drainage devices market.
Based on product type, the Middle East & Africa digital thoracic drainage devices market is segmented into single chamber and multiple chambers. The single chamber segment held 84.0% share of Middle East & Africa digital thoracic drainage devices market in 2022, amassing US$ 3.90 million. It is projected to garner US$ 5.16 million by 2030 to expand at 3.5% CAGR during 2022-2030.
Based on application, the Middle East & Africa digital thoracic drainage devices market is segmented into cardiac surgery, thoracic and pulmonary surgery, oncology and trauma, infectious diseases, and others. The thoracic and pulmonary surgery segment held 45.8% share of Middle East & Africa digital thoracic drainage devices market in 2022, amassing US$ 2.13 million. It is projected to garner US$ 2.95 million by 2030 to expand at 4.2% CAGR during 2022-2030.
Based on end user, the Middle East & Africa digital thoracic drainage devices market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held 48.9% share of Middle East & Africa digital thoracic drainage devices market in 2022, amassing US$ 2.27 million. It is projected to garner US$ 3.15 million by 2030 to expand at 4.1% CAGR during 2022-2030.
Based on country, the Middle East & Africa digital thoracic drainage devices market has been categorized into the UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. Our regional analysis states that the Rest of Middle East & Africa captured 27.7% share of Middle East & Africa digital thoracic drainage devices market in 2022. It was assessed at US$ 1.29 million in 2022 and is likely to hit US$ 1.60 million by 2030, exhibiting a CAGR of 2.8% during 2022-2030.
Key players operating in the Middle East & Africa digital thoracic drainage devices market are Cardinal Health Inc, Getinge AB, Medela AG, Redax SpA, and Teleflex Inc, among others.
Companies Mentioned
- Cardinal Health Inc
- Getinge AB
- Medela AG
- Redax SpA
- Teleflex Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 66 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value in 2022 | 4.65 Million |
| Forecasted Market Value by 2030 | 6.23 Million |
| Compound Annual Growth Rate | 3.7% |
| Regions Covered | Africa, Middle East |
| No. of Companies Mentioned | 5 |
